Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling mtor signaling'

Search results for: 'research area pi3k akt signaling mtor signaling'

Items 21-30 of 102

Page
per page
  1. CHIR-99021 (CT99021) HCl
    A8396 CHIR-99021 (CT99021) HCl
    Target: GSK-3
    Summary: GSK-3α/β inhibitor
      ≥25.1 mg/mL
  2. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL
  3. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL
  4. Wnt-C59
    A8685 Wnt-C59
     2 Citation
    Target: PORCN
    Summary: PORCN inhibitor,highly potent and selective
      .95 mg/mL
      insoluble in H2O; ≥18
  5. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
  6. SB 203580
    A8254 SB 203580
     9 Citation
    Target: p38|PKB
    Summary: P38 MAP kinase inhibitor
      insoluble in H2O; ≥18.872 mg/mL
  7. ICG 001
    A8217 ICG 001
     1 Citation
    Summary: Wnt/β-catenin pathway inhibitor
      ≥27.43 mg/mL
  8. LDN-193189
    A8324 LDN-193189
    Target: BMP and Other Activin Receptors
    Summary: ALK inhibitor,potent and selective
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  9. GDC-0879
    A5071 GDC-0879
     1 Citation
    Target: Raf
    Summary: B-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL
  10. PD184352 (CI-1040)
    A1792 PD184352 (CI-1040)
    Target: MEK
    Summary: Selective MEK inhibitor
      ≥47.9 mg/mL

Items 21-30 of 102

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 2item
  2. Apoptosis 1 item
  3. Chromatin/Epigenetics 4item
  4. Metabolism 3item
  5. MAPK Signaling 19item
  6. Tyrosine Kinase 9item
  7. DNA Damage/DNA Repair 6item
  8. PI3K/Akt/mTOR Signaling 41item
  9. Cell Cycle/Checkpoint 1 item
  10. Ubiquitination/ Proteasome 2item
  11. JAK/STAT Signaling 8item
  12. TGF-β / Smad Signaling 12item
  13. Stem Cell 13item
  14. Membrane Transporter/Ion Channel 1 item
  15. Endocrinology and Hormones 1 item
  16. Neuroscience 3item
  17. Obesity, Appetite Control & Diabetes 2item
  18. Other Signal Transduction 2item
  19. Immunology/Inflammation 1 item
  20. Cardiovascular 1 item
Reversibility
  1. Reversible 4item
  2. Irreversible 1 item
Target
  1. Histone Deacetylases (HDACs) 1 item
  2. Akt 5item
  3. PI3K 22item
  4. Raf 6item
  5. mTOR 15item
  6. Androgen Receptors 1 item
  7. GSK-3 5item
  8. P-glycoprotein (P-gp) 1 item
  9. PLK 1 item
  10. Eph Receptors 1 item
  11. VEGFR 4item
  12. PDGFR 2item
  13. Phosphodiesterases (PDEs) 1 item
  14. p38 4item
  15. PKB 1 item
  16. JNK 4item
  17. Bcr-Abl 1 item
  18. MEK 5item
  19. PORCN 1 item
  20. FGFR 1 item
  21. GABAB Receptors 1 item
  22. Smoothened 1 item
  23. Src 1 item
  24. STAT 4item
  25. EGFR 2item
  26. Hedgehog 1 item
  27. BMP and Other Activin Receptors 2item
  28. JAK 2item
  29. Syk 1 item
  30. DNA-PK 6item
  31. HSP90 1 item
  32. TNKS 1 item
  33. Toll-like receptors (TLRs) 1 item
  34. ERK 1 item
  35. PKC 3item
  36. Melanocortin (MC) Receptors 1 item
  37. Fatty-acid-binding proteins (FABPs) 1 item
  38. ATM/ATR 1 item
  39. P110 1 item
  40. Hck 1 item
  41. NO Donors / Precursors 1 item
  42. IL Receptors 1 item
  43. PKD 1 item
  44. ATM 1 item
Reported Experiments
  1. Animal Experiments 94item
  2. Cell Experiments 58item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Bladder Cancer 1 item
  4. Breast Cancer 23item
  5. Cancer 67item
  6. Cervical Cancer 2item
  7. Cholangiocarcinoma 1 item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Colon Cancer 10item
  10. Colon Carcinoma 1 item
  11. Colorectal Cancer 11item
  12. Glioblastoma 11item
  13. Glioma 4item
  14. Hepatocellular Carcinoma 1 item
  15. Leukemia 5item
  16. Liver Cancer 1 item
  17. Lung Cancer 7item
  18. Lymphoma 2item
  19. Melanoma 6item
  20. Multiple Myeloma 1 item
  21. Myeloma 1 item
  22. Neuroblastoma 2item
  23. Non-small Cell Lung Cancer 6item
  24. Ovarian Cancer 7item
  25. Pancreatic Cancer 10item
  26. Pancreatic Carcinoma 2item
  27. Prostate Cancer 11item
  28. Pulmonary Arterial Hypertension 1 item
  29. Pulmonary Fibrosis 1 item
  30. Renal Cancer 2item
  31. Rheumatoid Arthritis 2item
  32. Thyroid Cancer 2item
  33. Type 2 Diabetes 2item